Cannon Financial Strategists’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$552K Buy
4,294
+106
+3% +$12.4K 0.06% 72
2026
Q1
$504K Buy
4,188
+73
+2% +$8.43K 0.07% 63
2025
Q4
$433K Buy
4,115
+449
+12% +$42.1K 0.06% 67
2025
Q3
$308K Hold
3,666
0.04% 75
2025
Q2
$290K Sell
3,666
-12
-0.3% -$954 0.05% 76
2025
Q1
$330K Hold
3,678
0.06% 69
2024
Q4
$366K Sell
3,678
-238
-6% -$24.5K 0.06% 67
2024
Q3
$445K Sell
3,916
-169
-4% -$20.1K 0.08% 64
2024
Q2
$506K Hold
4,085
0.1% 58
2024
Q1
$539K Buy
4,085
+380
+10% +$46.8K 0.11% 57
2023
Q4
$404K Buy
3,705
+13
+0.4% +$1.35K 0.09% 60
2023
Q3
$380K Buy
3,692
+156
+4% +$16.8K 0.1% 60
2023
Q2
$408K Hold
3,536
0.11% 61
2023
Q1
$376K Sell
3,536
-197
-5% -$21.3K 0.13% 54
2022
Q4
$414K Buy
3,733
+42
+1% +$4.29K 0.15% 49
2022
Q3
$318K Hold
3,691
0.13% 56
2022
Q2
$337K Buy
3,691
+95
+3% +$8.42K 0.13% 58
2022
Q1
$295K Buy
3,596
+22
+0.6% +$1.74K 0.11% 55
2021
Q4
$274K Hold
3,574
0.1% 56
2021
Q3
$268K Hold
3,574
0.1% 56
2021
Q2
$278K Sell
3,574
-172
-5% -$12.8K 0.11% 54
2021
Q1
$276K Hold
3,746
0.12% 50
2020
Q4
$292K Hold
3,746
0.14% 50
2020
Q3
$296K Sell
3,746
-47
-1% -$3.68K 0.16% 45
2020
Q2
$280K Buy
+3,793
New +$286K 0.17% 43

Other funds holding MRK

Cannon Financial Strategists's MRK Position: Q2 2026 in Review

Cannon Financial Strategists increased its Merck (MRK) stake by 2.5% in Q2 2026, buying an estimated $12.4K and bringing the position to 4,294 shares worth $552K. The position accounts for 0.06% of the portfolio, ranked #72.

Cannon Financial Strategists first reported a position in MRK in Q2 2020 and has held it in 25 quarters since. 3,850 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Cannon Financial Strategists held 4,294 shares of Merck worth $552K as of Q2 2026.
  • Cannon Financial Strategists bought 106 Merck shares in Q2 2026, an estimated $12.4K.
  • Merck made up 0.06% of Cannon Financial Strategists's portfolio in Q2 2026, its #72 holding.
  • Cannon Financial Strategists first reported a position in Merck in Q2 2020 and has held it in 25 quarters since.
  • 3,850 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Cannon Financial Strategists's 13F filing for Q2 2026, filed 7 Aug 2026.